Current Medical Science

, Volume 38, Issue 6, pp 997–1004 | Cite as

Annexin A1 Mimetic Peptide AC2-26 Inhibits Sepsis-induced Cardiomyocyte Apoptosis through LXA4/PI3K/AKT Signaling Pathway

  • Li Zhang
  • Yan-lei Zheng
  • Rong-hua Hu
  • Li Zhu
  • Chen-chen Hu
  • Fei Cheng
  • Shi Li
  • Jian-guo LiEmail author


The aim of the present study was to explore the effects of annexin A1 (ANXA1) mimetic peptide AC2-26 on sepsis-induced cardiomyocyte apoptosis in vivo and in vitro and the underlying mechanisms. In the in vivo study, a rat septic model was established by the cecal ligation and puncture (CLP). The rats were divided into control group, sepsis group and AC2-26 group. The rats in the AC2-26 group were intraperitoneally injected with AC2-26 (1 mg/kg) 2 h before CLP, and those in the control group and sepsis group were injected with the same volume of normal saline. The myocardial tissue was examined by hematoxylin and eosin (HE) staining and transmission electron microscopy (TEM). Furthermore, myocardial apoptosis was measured by terminal dUTP nick end-labeling (TUNEL) assay. In the in vitro study, H9C2 cells were cultured and divided into three groups: control group, in which cells were only given the basic culture medium; LPS group, in which cells were treated with 10 μg/mL LPS; AC2-26 group, in which cells were treated with 0.5 μmol/L AC2-26 2 h before 10 μg/mL LPS was given. The apoptosis of H9C2 cells was detected by flow cytometry. The levels of lipoxin A4 receptor (LXA4), phosphoinositide-3-kinase (PI3K) and protein kinase B (PKB or AKT) protein were measured by Western blotting, the activity of NF-κB and the level of TNF-α by ELISA and the activities of caspase-3/8 by using the caspase activity kits. The in vivo study showed that the myocardial pathological damage and myocardial ultrastructural damage were significantly alleviated and the myocardial apoptosis significantly decreased in the AC2-26 group as compared with the sepsis group (P<0.05 for all). The in vivo study revealed that the apoptosis of H9C2 cells was profoundly ameliorated in the AC2-26 group relative to the sepsis group (P<0.05). The protein expression levels of LXA4 were significantly up-regulated, and those of PI3K and AKT prominently down-regulated in the AC2-26 group when compared with those in the LPS group (P<0.05 for all). The activity of NF-κB was greatly inhibited and the level of TNF-α markedly decreased in the AC2-26 group as compared with those in the LPS group (P<0.05 for all). AC2-26 treatment also significantly suppressed the activities of caspase-3/8 in H9C2 cells. In conclusion, these findings suggest that AC2-26 may alleviate the sepsis-induced cardiomyocyte apoptosis in vivo and in vivo through the LXA4/PI3K/AKT signaling pathway.

Key words

sepsis AC2-26 H9C2 apoptosis inflammation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 2016,315(8):762–774CrossRefGoogle Scholar
  2. 2.
    Perner A, Rhodes A, Venkatesh B, et al. Sepsis: frontiers in supportive care, organisation and research. Intensive Care Med, 2017,43(4):496–508CrossRefGoogle Scholar
  3. 3.
    Russell JA, Boyd J, Nakada T, et al. Molecular mechanisms of sepsis. Contrib Microbiol, 2011,17(17): 48–85CrossRefGoogle Scholar
  4. 4.
    Liu C, Lo J, Kuo C, et al. Akt mediates 17β-estradiol and/or estrogen receptor-α inhibition of LPS-induced tumor necresis factor-α expression and myocardial cell apoptosis by suppressing the JNK1/2-NFκB pathway. J Cell Mol Med, 2009, 13(9B):3655–3667CrossRefGoogle Scholar
  5. 5.
    Franceschelli S, Pesce M, Ferrone A, et al. Biological Effect of Licochalcone C on the Regulation of PI3K/Akt/eNOS and NF-κB/iNOS/NO Signaling Pathways in H9c2 Cells in Response to LPS Stimulation. Int J Mol Sci, 2017,18(4):690–704CrossRefGoogle Scholar
  6. 6.
    Zaky A, Deem S, Bendjelid K, et al. Characterization of cardiac dysfunction in sepsis: an ongoing challenge. Shock, 2014,41(1):12–24CrossRefGoogle Scholar
  7. 7.
    Balija TM, Lowry SF. Lipopolysaccharide and sepsisassociated myocardial dysfunction. Curr Opin Infect Dis, 2011,24(3):248–253CrossRefGoogle Scholar
  8. 8.
    Lancel S, Joulin O, Favory R, et al. Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation, 2005,111(20):2596–2604CrossRefGoogle Scholar
  9. 9.
    Chopra M, Das P, Sharma AC. Caspase-3 knock-down reverses contractile dysfunction induced by sepsis in adult rat ventricular myocytes. Br J Pharmacol, 2010,160(1):93–100CrossRefGoogle Scholar
  10. 10.
    Marchant DJ, Boyd JH, Lin DC, et al. Inflammation in Myocardial Diseases. Circ Res, 2012,110(1):126–144CrossRefGoogle Scholar
  11. 11.
    Wu SH, Wang MJ, Lü J, et al. Signal transduction involved in lipoxin A4-induced protection of tubular epithelial cells against hypoxia/reoxygenation injury. Mol Med Rep, 2017,15(4):1682–1692CrossRefGoogle Scholar
  12. 12.
    Yang Y, Cheng Y, Lian QQ, et al. Contribution of CFTR to alveolar fluid clearance by lipoxin A4 via PI3K/Akt pathway in LPS-induced acute lung injury. Mediators Inflamm, 2013,2013(6):862 628–862 638Google Scholar
  13. 13.
    Jarrah AA, Schwarskopf M, Wang ER, et al. SDF-1 induces TNF-mediated apoptosis in cardiac myocytes. Apoptosis, 2018,23(1):79–91CrossRefGoogle Scholar
  14. 14.
    Peshavariya HM, Taylor CJ, Goh C, et al. Annexin peptide Ac2-26 suppresses TNFα-induced inflammatory responses via inhibition of Rac1-dependent NADPH oxidase in human endothelial cells. PLoS One, 2013,8(4):e60790–60800CrossRefGoogle Scholar
  15. 15.
    Piliponsky AM, Chen CC, Nishimura T, et al. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med, 2016,14(4):392–398CrossRefGoogle Scholar
  16. 16.
    Huang SJ, Nalos M, Mclean AS. Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A metaanalysis. Crit Care, 2013, 17(3):R96CrossRefGoogle Scholar
  17. 17.
    Jia Z, Wang J, Shi Q, et al. SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition. Apoptosis, 2016,21(2):174–183CrossRefGoogle Scholar
  18. 18.
    Huang N, Wang F, Wang Y, et al. Ulinastatin improves survival of septic mice by suppressing inflammatory response and lymphocyte apoptosis. J Surg Res, 2013,182(2):296–302CrossRefGoogle Scholar
  19. 19.
    Balija TM, Lowry SF. Lipopolysaccharide and sepsisassociated myocardial dysfunction. Curr Opin Infect Dis, 2011,24(3):248–253CrossRefGoogle Scholar
  20. 20.
    Ryu JK, Kim SJ, Rah SH, et al. Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer. Immunity, 2016,46(1):1–13Google Scholar
  21. 21.
    He Z, Gao Y, Deng Y, et al. Lipopolysaccharide Induces Lung Fibroblast Proliferation through Toll-Like Receptor 4 Signaling and the Phosphoinositide 3-Kinase-Akt Pathway. PLoS One, 2012,7(4):e35 926–35 933CrossRefGoogle Scholar
  22. 22.
    Xia M, Tong JH, Ji NN, et al. Tramadol regulates proliferation, migration and invasion via PTEN/PI3K/AKT signaling in lung adenocarcinoma cells. Eur Rev Med Pharmacol Sci, 2016,20(12):2573–2580Google Scholar
  23. 23.
    Meng YY, Liu Y, Hu ZF, et al. Sanguinarine attenuates lipopolysaccharide-induced inflammation and apoptosis by inhibiting the TLR4/NF-κB pathway in H9c2 cardiomyocytes. Curr Med Sci, 2018,38(2):204–211CrossRefGoogle Scholar
  24. 24.
    Lin KH, Kuo WW, Shibu MA, et al. E2/ER β Enhances Calcineurin Protein Degradation and PI3K/Akt/MDM2 Signal Transduction to Inhibit ISO-Induced Myocardial Cell Apoptosis. Int J Mol Sci, 2017,18(4):892–906CrossRefGoogle Scholar
  25. 25.
    Park JJ, Lim KH, Baek KH. Annexin-1 regulated by HAUSP is essential for UV-induced damage response. Cell Death Dis, 2015,6(2):e1654-1669CrossRefGoogle Scholar
  26. 26.
    Gavins FNE, Hickey MJ. Annexin A1 and the regulation of innate and adaptive immunity. Front Immunol, 2012, 3(E9):354Google Scholar
  27. 27.
    Trentin PG, Ferreira TP, Arantes AC, et al. Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice. Br J Pharmacol, 2015,172(12):3058–3071CrossRefGoogle Scholar
  28. 28.
    Liao W, Wu SY, Wu GC, et al. Ac2-26, an Annexin A1 Peptide, Attenuates Ischemia-Reperfusion-Induced Acute Lung Injury. Int J Mol Sci, 2017,18(8):1771–1787CrossRefGoogle Scholar
  29. 29.
    Hanson J, Ferreirós N, Pirotte B, et al. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A4. Biochem Pharmacol, 2013,85(12):1795–1802CrossRefGoogle Scholar
  30. 30.
    Gavins FN. Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? Trends Pharmacol Sci, 2010,31(6):266–276CrossRefGoogle Scholar
  31. 31.
    Shi Y, Pan H, Zhang H Z, et al. Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-κB and PI3K/Akt signaling pathway in mice. Eur Rev Med Pharmacol Sci, 2017,21(8):1850–1859Google Scholar
  32. 32.
    Gewirtz AT, Collierhyams LS, Young AN, et al. Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol, 2002,168(10):5260–5267CrossRefGoogle Scholar
  33. 33.
    Yang Y, Cheng Y, Lian QQ, et al. Contribution of CFTR to alveolar fluid clearance by lipoxin A4 via PI3K/Akt pathway in LPS-induced acute lung injury. Mediators Inflamm, 2013,2013(6):862628Google Scholar
  34. 34.
    Wang J, Zhen L, Klug MG, et al. Involvement of caspase 3-and 8-like proteases in ceramide-induced apoptosis of cardiomyocytes. J Card Failure, 2000,6(3):243–249CrossRefGoogle Scholar
  35. 35.
    Pan YL, Han ZY, He SF, et al. miR 133b 5p contributes to hypoxic preconditioning mediated cardioprotection by inhibiting the activation of caspase 8 and caspase-3 in cardiomyocytes. Mol Med Rep, 2018,17(5):7097–7104Google Scholar

Copyright information

© Huazhong University of Science and Technology 2018

Authors and Affiliations

  • Li Zhang
    • 1
  • Yan-lei Zheng
    • 2
  • Rong-hua Hu
    • 2
  • Li Zhu
    • 2
  • Chen-chen Hu
    • 2
  • Fei Cheng
    • 2
  • Shi Li
    • 2
  • Jian-guo Li
    • 1
    Email author
  1. 1.Intensive Care UnitZhongnan Hospital of Wuhan UniversityWuhanChina
  2. 2.Intensive Care UnitHubei Cancer HospitalWuhanChina

Personalised recommendations